Baird Adjusts Price Target on Leidos Holdings to $150 From $125, Maintains Neutral Rating

Baird adjusted its price target on Leidos Holdings to $150 from $125 and kept a Neutral rating, according to the firm. The article also outlines Leidos’ business segment mix and describes Baird’s composite rating methodology based on valuation, EPS revisions, and visibility.

Original reporting
Published Aug 5, 2026, 10:42 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LDOS
Neutral
medium confidence
Mentioned
$LDOS
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$LDOSNeutralLow
01

Why it matters

This is primarily an analyst valuation update (price target up, rating unchanged). The lack of new operational or financial facts reduces trading urgency.

02

Market read

Valuation expectations for LDOS shift upward slightly, but the maintained Neutral rating implies no strong catalyst for a re-rating.

03

What to watch

Without details on EPS revisions, backlog, or contract wins, traders may discount the PT change as low-conviction.

Relevance 4/10Novelty 3/10Timing: today (analyst note update)

Background

The text describes Leidos’ business segment mix and general rating methodology, but does not add new company events.

Company-level read

Ticker impact

$LDOSNeutralMedium confidence
Context

Baird raised its price target on Leidos Holdings to $150 from $125 while keeping a Neutral rating, signaling a valuation view change.

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than thesis-driven.

Evidence & confidence

The article provides only the analyst PT/rating update and no new company-specific operational or financial datapoints.

Market effects

Minor read-through for defense and government-services analyst sentiment, but no sector-wide catalyst is provided.

None indicated.

None indicated.

Counterpoint

A higher price target with unchanged Neutral can reflect mechanical valuation adjustments rather than improved fundamentals, limiting follow-through.

Key entities

  • Leidos Holdings, Inc.

    Subject of the analyst price-target adjustment to $150 from $125, with a maintained Neutral rating.

  • Baird

    Broker/analyst issuing the price target change and rating.

Related articles

$LDOSMedAI 8/10

Leidos Holdings, Inc. Q2 2026 Earnings Call Summary

Leidos Holdings reported record Q2 2026 revenue of $4.6 billion and a 1.1 book-to-bill ratio, with Defense at a 2.2 book-to-bill. Full-year revenue guidance was raised by $100 million at the midpoint. Health faces VA incentive payment suspension, while Homeland grew 32%. Capex guidance was cut to about $250 million and share repurchases were authorized.

$LDOSMedAI 8/10

12 Companies Win Spots on DHS $1.5B Counter-Drone IDIQ

DHS awarded 14 positions on a $1.5B counter-drone IDIQ, split into Track 1 (ceiling $1.01B) for hardware and services and Track 2 (ceiling $489M) for comprehensive services, per USAspending. Leidos and BAE Systems won both tracks; others received single-track spots. Ordering runs Aug. 1, 2026 to July 31, 2031, with a $250M minimum guarantee at award.

$LDOSMedAI 8/10

Leidos Secures $64.8M Contract to Continue Modernizing Naval Intelligence Communications Systems

Leidos said it won a contract with the Office of Naval Intelligence worth up to $64.8 million, including a base year and four option years, to continue modernizing naval intelligence communications infrastructure. The work builds on Leidos efforts since 2021 and supports the Hopper Global Communications Center, aimed at secure information sharing and technology integration, according to the company.

$LDOSMedAI 8/10

Why Leidos (LDOS) Stock Is Up Today

Leidos Holdings (LDOS) shares rose about 9.3% after the company reported Q2 2026 results and raised guidance again, according to Leidos. Revenue was $4.56B (+7% YoY). Non-GAAP EPS guidance increased to $12.20 to $12.50, with operating cash flow around $1.85B. Net bookings were $4.9B and backlog $48.7B.

$LDOSMed

How Leidos looks at the military's electronic health record plan

Leidos said on its Q2 earnings call that the Defense Health Agency’s plan to move the MHS Genesis electronic health record from a lead systems integrator model to direct contracts with tech providers could increase government in-sourcing of integration and commercial technology. DHA plans bridge contracts with Leidos and targets 2027 for provider transitions. Leidos reported Q2 revenue of $4.5B and adjusted EBITDA $631M, and raised full-year revenue guidance to $18.2B-$18.4B.